N-Terminal Prohormone of Brain Natriuretic Peptide (One step test for NT -pro BNP ) - India CDSCO Medical Device Registration

N-Terminal Prohormone of Brain Natriuretic Peptide (One step test for NT -pro BNP ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000236_5b6607e060667f7999cf51328008a48b_0b5a3f17d26f626dabc7068256eeeb84. This device is marketed under the brand name Beta 2 - MG. The license holder is Cosmic Scientific Technologies, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class C

N-Terminal Prohormone of Brain Natriuretic Peptide (One step test for NT -pro BNP )

UID: IMP/IVD/2020/000236_5b6607e060667f7999cf51328008a48b_0b5a3f17d26f626dabc7068256eeeb84

Brand Name

Beta 2 - MG

License Holder

Cosmic Scientific Technologies

Device Class

Class C

Approving Authority

CDSCO

Product Information

One step test for NT -pro BNP/cTnl (Beta 2 - MG) is intended for in vitro quantitative determination of N terminal B type natriuretic peptide precursor/cardiac troponin I (Beta 2 - MG) in serum, plasma and whole blood. This test is used as an aid in the clinical diagnosis, prognosis and evaluation of Heart Failure (Beta 2 - MG), Acute Myocardial Infarction (Beta 2 - MG) and Acute Coronary Syndrome (Beta 2 - MG)